US · Healthcare

Nasus Pharma Ltd. (NSRX)

Drug Manufacturers - General

Nasus Pharma Ltd. (NSRX) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for NSRX

P/E ratio

18.00

Nasus Pharma Ltd. (NSRX) — FAQ

What is NSRX's P/E ratio?

The price-to-earnings (P/E) ratio for Nasus Pharma Ltd. (NSRX) is 18.00 (data as of 2026-05-23).

Does Nasus Pharma Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for Nasus Pharma Ltd. (NSRX). Check the MyAverix Finance app for the latest dividend data.

What sector is Nasus Pharma Ltd. in?

Nasus Pharma Ltd. (NSRX) is classified in the Healthcare sector (Drug Manufacturers - General industry).

What exchange is NSRX listed on?

NSRX is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)